Biotech stocks are off to the best start of the year since 2012 on heels of J.P. Morgan conference

Two new deals to the start the year and positive trial presentations at the J.P. Morgan Health Care conference, have breathed new life into some of last year's biggest stock losers....

Read More »

By: CNBC - Friday, 11 January

Related Posts